Store
GS3 · Industry

Pharma exports cross USD 30 billion

1 min readManufacturing & PLI
Battle IAS current affairs title card: Pharma exports cross USD 30 billion (GS3 · Industry, 21 February 2026)

What happened

  • Pharma exports crossed USD 30 billion, growing 9.4%; industry aims at double-digit growth in 2026-27 [PIB].

Background

  • Biopharma SHAKTI (₹10,000 crore) aims to cut import dependence in biologics [PIB].

Why it matters

  • Generics built the USD 30 billion; biologics are the next jump.

How to use this in Mains

GS-III Infrastructure: energy, ports, roads, airports, railways; investment models

  1. As per PIB (2026-02-21): pharma exports crossed USD 30 billion, growing 9.4%; industry aims at double-digit growth in 2026-27.
  2. Generics built the USD 30 billion; biologics are the next jump.
Quotable data point

Pharma exports crossed USD 30 billion, growing 9.4%.

PIB: Pharma exports, 21 Feb 2026

Exam angle

UPSC

Prelims: none.

Practice MCQs

Original practice questions (not PYQs).

Practice · UPSC

Pharma export growth cited in Feb 2026

Answer (b) & explanation

PIB.

Go deeper

ExplainerSemiconductors and India: What Chips Are, the Global Value Chain, India Semiconductor Mission, New Fabs and Packaging Units, Challenges and the Way Ahead (UPSC Notes + PYQs)ExplainerProduction Linked Incentive (PLI) Scheme: Rationale, 14 Sectors, Design, Achievements in Mobiles and Electronics, Criticism and Reforms (UPSC Notes + PYQs)

Official source: PIB: Pharma exports, 21 Feb 2026

facts from cited sources only; faculty review pending